​

Synvaccine's platform technology for viral design is the first fully integrated computer-aided design and manufacturing (CAD/CAM) system for synthetic, rationally designed viruses. Our first line of products in development are viral vaccines for several major human pathogens.

 

The company owns exclusive licences for disruptive synthetic biology technologies for computationally designing and fabricating viruses, positioned to leapfrog currently used, trial and error-based technologies for developing viruses for biotechnology.